Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126416181 | 12641618 | 1 | I | 20160706 | 20160807 | 20160810 | 20160810 | EXP | RO-ABBVIE-16P-135-1696151-00 | ABBVIE | 61.56 | YR | F | Y | 0.00000 | 20160810 | CN | COUNTRY NOT SPECIFIED | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126416181 | 12641618 | 1 | PS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | 2-0-0: 2 IN THE MORNING | 1060132 | 206619 | FILM-COATED TABLET | ||||||||
| 126416181 | 12641618 | 2 | SS | VIEKIRAX | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 1060132 | 206619 | |||||||||||
| 126416181 | 12641618 | 3 | SS | EXVIERA | DASABUVIR | 1 | Oral | 1-0-1: 1 IN THE MORNING AND 1 IN THE EVENING | 1059033 | 206619 | FILM-COATED TABLET | ||||||||
| 126416181 | 12641618 | 4 | SS | EXVIERA | DASABUVIR | 1 | 1059033 | 206619 | |||||||||||
| 126416181 | 12641618 | 5 | SS | REBETOL | RIBAVIRIN | 1 | Oral | Y | UNKNOWN | 0 | CAPSULE | BID | |||||||
| 126416181 | 12641618 | 6 | SS | REBETOL | RIBAVIRIN | 1 | Y | UNKNOWN | 0 | ||||||||||
| 126416181 | 12641618 | 7 | C | URSOFALK | URSODIOL | 1 | Oral | 0 | CAPSULE | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126416181 | 12641618 | 1 | Hepatitis C |
| 126416181 | 12641618 | 2 | Hepatic cirrhosis |
| 126416181 | 12641618 | 3 | Hepatitis C |
| 126416181 | 12641618 | 4 | Hepatic cirrhosis |
| 126416181 | 12641618 | 5 | Hepatitis C |
| 126416181 | 12641618 | 6 | Hepatic cirrhosis |
| 126416181 | 12641618 | 7 | Liver disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126416181 | 12641618 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126416181 | 12641618 | Asthenia | |
| 126416181 | 12641618 | Decreased appetite | |
| 126416181 | 12641618 | Headache | |
| 126416181 | 12641618 | Hyperbilirubinaemia | |
| 126416181 | 12641618 | Hypoalbuminaemia | |
| 126416181 | 12641618 | Nausea | |
| 126416181 | 12641618 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126416181 | 12641618 | 1 | 20160704 | 0 | ||
| 126416181 | 12641618 | 3 | 20160704 | 0 | ||
| 126416181 | 12641618 | 5 | 20160704 | 20160708 | 0 | |
| 126416181 | 12641618 | 7 | 20160708 | 0 |